ID POL_XMRV3 Reviewed; 1733 AA. AC Q2F7J3; DT 19-JAN-2010, integrated into UniProtKB/Swiss-Prot. DT 21-MAR-2006, sequence version 1. DT 27-MAR-2024, entry version 110. DE RecName: Full=Gag-Pol polyprotein; DE Short=Pr180gag-pol; DE Contains: DE RecName: Full=Matrix protein p15; DE Short=MA; DE Contains: DE RecName: Full=RNA-binding phosphoprotein p12; DE AltName: Full=pp12; DE Contains: DE RecName: Full=Capsid protein p30; DE Short=CA; DE Contains: DE RecName: Full=Nucleocapsid protein p10; DE Short=NC-pol; DE Contains: DE RecName: Full=Protease p14; DE Short=PR; DE EC=3.4.23.-; DE Contains: DE RecName: Full=Reverse transcriptase/ribonuclease H p80; DE Short=RT; DE EC=2.7.7.49; DE EC=2.7.7.7; DE EC=3.1.26.4; DE Contains: DE RecName: Full=Integrase p46; DE Short=IN; DE EC=2.7.7.- {ECO:0000250|UniProtKB:P03355}; DE EC=3.1.-.- {ECO:0000250|UniProtKB:P03355}; GN Name=gag-pol; OS Xenotropic MuLV-related virus (isolate VP35) (XMRV). OC Viruses; Riboviria; Pararnavirae; Artverviricota; Revtraviricetes; OC Ortervirales; Retroviridae; Orthoretrovirinae; Gammaretrovirus; OC Murine leukemia-related retroviruses. OX NCBI_TaxID=356663; OH NCBI_TaxID=9606; Homo sapiens (Human). RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC RNA], AND RETRACTED PAPER. RX PubMed=16609730; DOI=10.1371/journal.ppat.0020025; RA Urisman A., Molinaro R.J., Fischer N., Plummer S.J., Casey G., Klein E.A., RA Malathi K., Magi-Galluzzi C., Tubbs R.R., Ganem D., Silverman R.H., RA DeRisi J.L.; RT "Identification of a novel Gammaretrovirus in prostate tumors of patients RT homozygous for R462Q RNASEL variant."; RL PLoS Pathog. 2:E25-E25(2006). RN [2] RP RETRACTION NOTICE OF PUBMED:16609730. RX PubMed=23028303; RX DOI=10.1371/annotation/7e2efc01-2e9b-4e9b-aef0-87ab0e4e4732; RA Urisman A., Molinaro R.J., Fischer N., Plummer S.J., Casey G., Klein E.A., RA Malathi K., Magi-Galluzzi C., Tubbs R.R., Ganem D., Silverman R.H., RA DeRisi J.L.; RL PLoS Pathog. 8:0-0(2012). RN [3] {ECO:0007744|PDB:3V1O, ECO:0007744|PDB:3V1Q, ECO:0007744|PDB:3V1R} RP X-RAY CRYSTALLOGRAPHY (1.88 ANGSTROMS) OF 1154-1328 IN COMPLEX WITH MN(2+) RP AND BETA-THUJAPLICINOL, AND COFACTOR (REVERSE TRANSCRIPTASE/RIBONUCLEASE H RP P80). RX PubMed=22366278; DOI=10.1016/j.jsb.2012.02.006; RA Zhou D., Chung S., Miller M., Grice S.F., Wlodawer A.; RT "Crystal structures of the reverse transcriptase-associated ribonuclease H RT domain of xenotropic murine leukemia-virus related virus."; RL J. Struct. Biol. 177:638-645(2012). CC -!- FUNCTION: [Gag-Pol polyprotein]: Plays a role in budding and is CC processed by the viral protease during virion maturation outside the CC cell. During budding, it recruits, in a PPXY-dependent or independent CC manner, Nedd4-like ubiquitin ligases that conjugate ubiquitin molecules CC to Gag, or to Gag binding host factors. Interaction with HECT ubiquitin CC ligases probably link the viral protein to the host ESCRT pathway and CC facilitate release. {ECO:0000250|UniProtKB:P03332}. CC -!- FUNCTION: [Matrix protein p15]: Targets Gag and gag-pol polyproteins to CC the plasma membrane via a multipartite membrane binding signal, that CC includes its myristoylated N-terminus. Also mediates nuclear CC localization of the pre-integration complex. CC {ECO:0000250|UniProtKB:P03332}. CC -!- FUNCTION: [Capsid protein p30]: Forms the spherical core of the virion CC that encapsulates the genomic RNA-nucleocapsid complex. CC {ECO:0000250|UniProtKB:P03336}. CC -!- FUNCTION: [Nucleocapsid protein p10]: Involved in the packaging and CC encapsidation of two copies of the genome (By similarity). Binds with CC high affinity to conserved UCUG elements within the packaging signal, CC located near the 5'-end of the genome (By similarity). This binding is CC dependent on genome dimerization (By similarity). Acts as a nucleic CC acid chaperone which is involved in rearrangement of nucleic acid CC secondary structures during gRNA retrotranscription (By similarity). CC {ECO:0000250|UniProtKB:P03332, ECO:0000250|UniProtKB:P03355}. CC -!- FUNCTION: [Protease p14]: The aspartyl protease mediates proteolytic CC cleavages of Gag and Gag-Pol polyproteins during or shortly after the CC release of the virion from the plasma membrane. Cleavages take place as CC an ordered, step-wise cascade to yield mature proteins. This process is CC called maturation. Displays maximal activity during the budding process CC just prior to particle release from the cell. {ECO:0000255|PROSITE- CC ProRule:PRU00275}. CC -!- FUNCTION: [Reverse transcriptase/ribonuclease H p80]: RT is a CC multifunctional enzyme that converts the viral dimeric RNA genome into CC dsDNA in the cytoplasm, shortly after virus entry into the cell. This CC enzyme displays a DNA polymerase activity that can copy either DNA or CC RNA templates, and a ribonuclease H (RNase H) activity that cleaves the CC RNA strand of RNA-DNA heteroduplexes in a partially processive 3' to 5' CC endonucleasic mode. Conversion of viral genomic RNA into dsDNA requires CC many steps. A tRNA binds to the primer-binding site (PBS) situated at CC the 5' end of the viral RNA. RT uses the 3' end of the tRNA primer to CC perform a short round of RNA-dependent minus-strand DNA synthesis. The CC reading proceeds through the U5 region and ends after the repeated (R) CC region which is present at both ends of viral RNA. The portion of the CC RNA-DNA heteroduplex is digested by the RNase H, resulting in a ssDNA CC product attached to the tRNA primer. This ssDNA/tRNA hybridizes with CC the identical R region situated at the 3' end of viral RNA. This CC template exchange, known as minus-strand DNA strong stop transfer, can CC be either intra- or intermolecular. RT uses the 3' end of this newly CC synthesized short ssDNA to perform the RNA-dependent minus-strand DNA CC synthesis of the whole template. RNase H digests the RNA template CC except for a polypurine tract (PPT) situated at the 5' end of the CC genome. It is not clear if both polymerase and RNase H activities are CC simultaneous. RNase H probably can proceed both in a polymerase- CC dependent (RNA cut into small fragments by the same RT performing DNA CC synthesis) and a polymerase-independent mode (cleavage of remaining RNA CC fragments by free RTs). Secondly, RT performs DNA-directed plus-strand CC DNA synthesis using the PPT that has not been removed by RNase H as CC primers. PPT and tRNA primers are then removed by RNase H. The 3' and CC 5' ssDNA PBS regions hybridize to form a circular dsDNA intermediate. CC Strand displacement synthesis by RT to the PBS and PPT ends produces a CC blunt ended, linear dsDNA copy of the viral genome that includes long CC terminal repeats (LTRs) at both ends (By similarity). {ECO:0000250}. CC -!- FUNCTION: [Integrase p46]: Catalyzes viral DNA integration into the CC host chromosome, by performing a series of DNA cutting and joining CC reactions. This enzyme activity takes place after virion entry into a CC cell and reverse transcription of the RNA genome in dsDNA. The first CC step in the integration process is 3' processing. This step requires a CC complex comprising the viral genome, matrix protein and integrase. This CC complex is called the pre-integration complex (PIC). The integrase CC protein removes 2 nucleotides from each 3' end of the viral DNA, CC leaving recessed CA OH's at the 3' ends. In the second step that CC requires cell division, the PIC enters cell nucleus. In the third step, CC termed strand transfer, the integrase protein joins the previously CC processed 3' ends to the 5' ends of strands of target cellular DNA at CC the site of integration. The last step is viral DNA integration into CC host chromosome. {ECO:0000250|UniProtKB:P03355}. CC -!- CATALYTIC ACTIVITY: [Reverse transcriptase/ribonuclease H p80]: CC Reaction=a 2'-deoxyribonucleoside 5'-triphosphate + DNA(n) = CC diphosphate + DNA(n+1); Xref=Rhea:RHEA:22508, Rhea:RHEA-COMP:17339, CC Rhea:RHEA-COMP:17340, ChEBI:CHEBI:33019, ChEBI:CHEBI:61560, CC ChEBI:CHEBI:173112; EC=2.7.7.49; Evidence={ECO:0000255|PROSITE- CC ProRule:PRU00405}; CC -!- CATALYTIC ACTIVITY: [Reverse transcriptase/ribonuclease H p80]: CC Reaction=a 2'-deoxyribonucleoside 5'-triphosphate + DNA(n) = CC diphosphate + DNA(n+1); Xref=Rhea:RHEA:22508, Rhea:RHEA-COMP:17339, CC Rhea:RHEA-COMP:17340, ChEBI:CHEBI:33019, ChEBI:CHEBI:61560, CC ChEBI:CHEBI:173112; EC=2.7.7.7; Evidence={ECO:0000255|PROSITE- CC ProRule:PRU00405}; CC -!- CATALYTIC ACTIVITY: [Protease p14]: CC Reaction=Endonucleolytic cleavage to 5'-phosphomonoester.; EC=3.1.26.4; CC Evidence={ECO:0000255|PROSITE-ProRule:PRU00408}; CC -!- COFACTOR: [Reverse transcriptase/ribonuclease H p80]: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250}; CC Note=Binds 2 magnesium ions for reverse transcriptase polymerase CC activity. {ECO:0000250}; CC -!- COFACTOR: [Reverse transcriptase/ribonuclease H p80]: CC Name=Mn(2+); Xref=ChEBI:CHEBI:29035; CC Evidence={ECO:0000269|PubMed:22366278}; CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000250|UniProtKB:A1Z651}; CC Note=Binds 2 Mn(2+)/Mg(2+) ions for ribonuclease H (RNase H) activity CC (PubMed:22366278). Shows 4- to 6-fold increased rates of cleavage in CC the presence of Mn(2+) versus Mg2(2+) (By similarity). CC {ECO:0000250|UniProtKB:A1Z651, ECO:0000269|PubMed:22366278}; CC -!- COFACTOR: [Integrase p46]: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250}; CC Note=Magnesium ions are required for integrase activity. Binds at least CC 1, maybe 2 magnesium ions. {ECO:0000250}; CC -!- SUBUNIT: [Capsid protein p30]: Homohexamer, that further associates as CC homomultimer. The virus core is composed of a lattice formed from CC hexagonal rings, each containing six capsid monomers. The protease is a CC homodimer, whose active site consists of two apposed aspartic acid CC residues. The reverse transcriptase is a monomer. CC {ECO:0000250|UniProtKB:P03355}. CC -!- SUBUNIT: [Gag-Pol polyprotein]: Interacts (via PPXY motif) with host CC NEDD4 (By similarity). Interacts (via PSAP motif) with host TSG101 (By CC similarity). Interacts (via LYPX(n)L motif) with host PDCD6IP (By CC similarity). {ECO:0000250|UniProtKB:P03355}. CC -!- SUBUNIT: [Reverse transcriptase/ribonuclease H p80]: The reverse CC transcriptase is a monomer (Potential). Interacts (via RNase domains) CC with host release factor ETF1; this interaction is essential for CC translational readthrough of amber codon between viral gag and pol CC genes, as well as for viral replication. CC {ECO:0000250|UniProtKB:P03355}. CC -!- SUBUNIT: [Integrase p46]: Homodimer. {ECO:0000250|UniProtKB:P03355}. CC -!- SUBCELLULAR LOCATION: [Gag-Pol polyprotein]: Host cell membrane CC {ECO:0000305}; Lipid-anchor {ECO:0000305}. CC -!- SUBCELLULAR LOCATION: [Matrix protein p15]: Virion {ECO:0000305}. CC -!- SUBCELLULAR LOCATION: [Capsid protein p30]: Virion {ECO:0000305}. CC -!- SUBCELLULAR LOCATION: [Nucleocapsid protein p10]: Virion {ECO:0000305}. CC -!- DOMAIN: [Gag-Pol polyprotein]: Late-budding domains (L domains) are CC short sequence motifs essential for viral particle release. They can CC occur individually or in close proximity within structural proteins. CC They interacts with sorting cellular proteins of the multivesicular CC body (MVB) pathway. Most of these proteins are class E vacuolar protein CC sorting factors belonging to ESCRT-I, ESCRT-II or ESCRT-III complexes. CC RNA-binding phosphoprotein p12 contains one L domain: a PPXY motif CC which potentially interacts with the WW domain 3 of NEDD4 E3 ubiquitin CC ligase. PPXY motif is essential for virus egress. Matrix protein p15 CC contains one L domain: a PTAP/PSAP motif, which potentially interacts CC with the UEV domain of TSG101. The junction between the matrix protein CC p15 and RNA-binding phosphoprotein p12 also contains one L domain: a CC LYPX(n)L motif which potentially interacts with PDCD6IP. Both PSAP and CC LYPX(n)L domains might play little to no role in budding and possibly CC drive residual virus release. contains. {ECO:0000250|UniProtKB:P03332}. CC -!- PTM: [Gag-Pol polyprotein]: Specific enzymatic cleavages by the viral CC protease yield mature proteins. The protease is released by CC autocatalytic cleavage. The polyprotein is cleaved during and after CC budding, this process is termed maturation. CC {ECO:0000250|UniProtKB:P03355}. CC -!- PTM: [Capsid protein p30]: Sumoylated; which is required for virus CC replication. {ECO:0000250|UniProtKB:P03355}. CC -!- PTM: [RNA-binding phosphoprotein p12]: Phosphorylated on serine CC residues. {ECO:0000250|UniProtKB:P03355}. CC -!- MISCELLANEOUS: [Gag-Pol polyprotein]: This protein is translated as a CC gag-pol fusion protein by episodic readthrough of the gag protein CC termination codon. Readthrough of the terminator codon TAG occurs CC between the codons for 536-Asp and 538-Gly. CC {ECO:0000250|UniProtKB:P03355}. CC -!- MISCELLANEOUS: [Nucleocapsid protein p10]: Nucleocapsid protein p10 CC released from Pol polyprotein (NC-pol) is a few amino acids shorter CC than the nucleocapsid protein p10 released from Gag polyprotein (NC- CC gag). {ECO:0000250}. CC -!- MISCELLANEOUS: [Reverse transcriptase/ribonuclease H p80]: The reverse CC transcriptase is an error-prone enzyme that lacks a proof-reading CC function. High mutations rate is a direct consequence of this CC characteristic. RT also displays frequent template swiching leading to CC high recombination rate. Recombination mostly occurs between homologous CC regions of the two copackaged RNA genomes. If these two RNA molecules CC derive from different viral strains, reverse transcription will give CC rise to highly recombinated proviral DNAs. {ECO:0000255|PROSITE- CC ProRule:PRU00405}. CC -!- CAUTION: Originally thought to be characterized from prostate tumors, CC the described gammaretrovirus XMRV is in fact laboratory-derived and CC there is no association of XMRV with prostate cancer. CC {ECO:0000305|PubMed:16609730, ECO:0000305|PubMed:23028303}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; DQ241301; ABB83225.1; -; Genomic_RNA. DR PDB; 3V1O; X-ray; 1.88 A; A=1154-1328. DR PDB; 3V1Q; X-ray; 2.00 A; A=1155-1328. DR PDB; 3V1R; X-ray; 2.80 A; A=1154-1328. DR PDBsum; 3V1O; -. DR PDBsum; 3V1Q; -. DR PDBsum; 3V1R; -. DR SMR; Q2F7J3; -. DR Proteomes; UP000008601; Genome. DR GO; GO:0020002; C:host cell plasma membrane; IEA:UniProtKB-SubCell. DR GO; GO:0016020; C:membrane; IEA:UniProtKB-KW. DR GO; GO:0019013; C:viral nucleocapsid; IEA:UniProtKB-KW. DR GO; GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW. DR GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW. DR GO; GO:0003887; F:DNA-directed DNA polymerase activity; IEA:UniProtKB-KW. DR GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW. DR GO; GO:0003964; F:RNA-directed DNA polymerase activity; IEA:UniProtKB-KW. DR GO; GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IEA:UniProtKB-EC. DR GO; GO:0039660; F:structural constituent of virion; IEA:UniProtKB-KW. DR GO; GO:0008270; F:zinc ion binding; IEA:InterPro. DR GO; GO:0015074; P:DNA integration; IEA:UniProtKB-KW. DR GO; GO:0006310; P:DNA recombination; IEA:UniProtKB-KW. DR GO; GO:0075713; P:establishment of integrated proviral latency; IEA:UniProtKB-KW. DR GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW. DR GO; GO:0046718; P:viral entry into host cell; IEA:UniProtKB-KW. DR GO; GO:0044826; P:viral genome integration into host DNA; IEA:UniProtKB-KW. DR GO; GO:0019068; P:virion assembly; IEA:InterPro. DR CDD; cd09273; RNase_HI_RT_Bel; 1. DR CDD; cd06095; RP_RTVL_H_like; 1. DR CDD; cd03715; RT_ZFREV_like; 1. DR Gene3D; 1.10.340.70; -; 1. DR Gene3D; 2.30.30.850; -; 1. DR Gene3D; 3.10.20.370; -; 1. DR Gene3D; 3.30.70.270; -; 2. DR Gene3D; 2.40.70.10; Acid Proteases; 1. DR Gene3D; 1.10.150.180; Gamma-retroviral matrix domain; 1. DR Gene3D; 3.10.10.10; HIV Type 1 Reverse Transcriptase, subunit A, domain 1; 1. DR Gene3D; 1.10.375.10; Human Immunodeficiency Virus Type 1 Capsid Protein; 1. DR Gene3D; 3.30.420.10; Ribonuclease H-like superfamily/Ribonuclease H; 2. DR Gene3D; 4.10.60.10; Zinc finger, CCHC-type; 1. DR InterPro; IPR001969; Aspartic_peptidase_AS. DR InterPro; IPR043502; DNA/RNA_pol_sf. DR InterPro; IPR000840; G_retro_matrix. DR InterPro; IPR036946; G_retro_matrix_sf. DR InterPro; IPR039464; Gag-pol_Znf-H3C2. DR InterPro; IPR002079; Gag_p12. DR InterPro; IPR003036; Gag_P30. DR InterPro; IPR001584; Integrase_cat-core. DR InterPro; IPR040643; MLVIN_C. DR InterPro; IPR001995; Peptidase_A2_cat. DR InterPro; IPR021109; Peptidase_aspartic_dom_sf. DR InterPro; IPR018061; Retropepsins. DR InterPro; IPR008919; Retrov_capsid_N. DR InterPro; IPR010999; Retrovr_matrix. DR InterPro; IPR043128; Rev_trsase/Diguanyl_cyclase. DR InterPro; IPR012337; RNaseH-like_sf. DR InterPro; IPR002156; RNaseH_domain. DR InterPro; IPR036397; RNaseH_sf. DR InterPro; IPR000477; RT_dom. DR InterPro; IPR041577; RT_RNaseH_2. DR InterPro; IPR001878; Znf_CCHC. DR InterPro; IPR036875; Znf_CCHC_sf. DR PANTHER; PTHR33166:SF1; CORE SHELL PROTEIN GAG P30 DOMAIN-CONTAINING PROTEIN; 1. DR PANTHER; PTHR33166; GAG_P30 DOMAIN-CONTAINING PROTEIN; 1. DR Pfam; PF01140; Gag_MA; 1. DR Pfam; PF01141; Gag_p12; 1. DR Pfam; PF02093; Gag_p30; 1. DR Pfam; PF18697; MLVIN_C; 1. DR Pfam; PF00075; RNase_H; 1. DR Pfam; PF17919; RT_RNaseH_2; 1. DR Pfam; PF00665; rve; 1. DR Pfam; PF00077; RVP; 1. DR Pfam; PF00078; RVT_1; 1. DR Pfam; PF00098; zf-CCHC; 1. DR Pfam; PF16721; zf-H3C2; 1. DR SMART; SM00343; ZnF_C2HC; 1. DR SUPFAM; SSF50630; Acid proteases; 1. DR SUPFAM; SSF56672; DNA/RNA polymerases; 1. DR SUPFAM; SSF47836; Retroviral matrix proteins; 1. DR SUPFAM; SSF47943; Retrovirus capsid protein, N-terminal core domain; 1. DR SUPFAM; SSF57756; Retrovirus zinc finger-like domains; 1. DR SUPFAM; SSF53098; Ribonuclease H-like; 2. DR PROSITE; PS50175; ASP_PROT_RETROV; 1. DR PROSITE; PS00141; ASP_PROTEASE; 1. DR PROSITE; PS50994; INTEGRASE; 1. DR PROSITE; PS50879; RNASE_H_1; 1. DR PROSITE; PS50878; RT_POL; 1. DR PROSITE; PS50158; ZF_CCHC; 1. PE 1: Evidence at protein level; KW 3D-structure; Aspartyl protease; Capsid protein; Coiled coil; KW DNA integration; DNA recombination; DNA-binding; KW DNA-directed DNA polymerase; Endonuclease; Host cell membrane; KW Host membrane; Hydrolase; Lipoprotein; Magnesium; Manganese; Membrane; KW Metal-binding; Multifunctional enzyme; Myristate; Nuclease; KW Nucleotidyltransferase; Phosphoprotein; Protease; KW RNA suppression of termination; RNA-binding; RNA-directed DNA polymerase; KW Transferase; Ubl conjugation; Viral genome integration; KW Viral matrix protein; Viral nucleoprotein; Virion; KW Virus entry into host cell; Zinc; Zinc-finger. FT INIT_MET 1 FT /note="Removed; by host" FT /evidence="ECO:0000250" FT CHAIN 2..1733 FT /note="Gag-Pol polyprotein" FT /evidence="ECO:0000250" FT /id="PRO_0000390852" FT CHAIN 2..129 FT /note="Matrix protein p15" FT /evidence="ECO:0000250" FT /id="PRO_0000390853" FT CHAIN 130..213 FT /note="RNA-binding phosphoprotein p12" FT /evidence="ECO:0000250" FT /id="PRO_0000390854" FT CHAIN 214..476 FT /note="Capsid protein p30" FT /evidence="ECO:0000250" FT /id="PRO_0000390855" FT CHAIN 477..532 FT /note="Nucleocapsid protein p10" FT /evidence="ECO:0000250" FT /id="PRO_0000390856" FT CHAIN 533..657 FT /note="Protease p14" FT /evidence="ECO:0000250" FT /id="PRO_0000390857" FT CHAIN 658..1328 FT /note="Reverse transcriptase/ribonuclease H p80" FT /evidence="ECO:0000250" FT /id="PRO_0000390858" FT CHAIN 1329..1733 FT /note="Integrase p46" FT /evidence="ECO:0000250" FT /id="PRO_0000390859" FT DOMAIN 559..629 FT /note="Peptidase A2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00275" FT DOMAIN 739..930 FT /note="Reverse transcriptase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00405" FT DOMAIN 1172..1318 FT /note="RNase H type-1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00408" FT DOMAIN 1442..1600 FT /note="Integrase catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00457" FT ZN_FING 500..517 FT /note="CCHC-type" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00047" FT REGION 99..218 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 474..495 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 511..550 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COILED 436..476 FT /evidence="ECO:0000255" FT MOTIF 109..112 FT /note="PTAP/PSAP motif" FT MOTIF 128..132 FT /note="LYPX(n)L motif" FT MOTIF 161..164 FT /note="PPXY motif" FT COMPBIAS 99..123 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 164..190 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 564 FT /note="Protease; shared with dimeric partner" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00275" FT BINDING 721 FT /ligand="RNA" FT /ligand_id="ChEBI:CHEBI:33697" FT /ligand_note="RNA template" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 771 FT /ligand="RNA" FT /ligand_id="ChEBI:CHEBI:33697" FT /ligand_note="RNA template" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 773 FT /ligand="RNA" FT /ligand_id="ChEBI:CHEBI:33697" FT /ligand_note="RNA template" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 787 FT /ligand="RNA" FT /ligand_id="ChEBI:CHEBI:33697" FT /ligand_note="RNA template" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 807 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="1" FT /ligand_note="catalytic; for reverse transcriptase FT activity" FT /evidence="ECO:0000250" FT BINDING 851 FT /ligand="RNA" FT /ligand_id="ChEBI:CHEBI:33697" FT /ligand_note="RNA template" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 853 FT /ligand="RNA" FT /ligand_id="ChEBI:CHEBI:33697" FT /ligand_note="RNA template" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 881 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="1" FT /ligand_note="catalytic; for reverse transcriptase FT activity" FT /evidence="ECO:0000250" FT BINDING 882 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="1" FT /ligand_note="catalytic; for reverse transcriptase FT activity" FT /evidence="ECO:0000250" FT BINDING 941 FT /ligand="DNA" FT /ligand_id="ChEBI:CHEBI:16991" FT /ligand_note="DNA primer" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 955 FT /ligand="DNA" FT /ligand_id="ChEBI:CHEBI:16991" FT /ligand_note="DNA primer" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 958 FT /ligand="DNA" FT /ligand_id="ChEBI:CHEBI:16991" FT /ligand_note="DNA primer" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 966 FT /ligand="DNA" FT /ligand_id="ChEBI:CHEBI:16991" FT /ligand_note="DNA primer" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 1054 FT /ligand="RNA" FT /ligand_id="ChEBI:CHEBI:33697" FT /ligand_note="RNA template" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 1055 FT /ligand="RNA" FT /ligand_id="ChEBI:CHEBI:33697" FT /ligand_note="RNA template" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 1063 FT /ligand="DNA" FT /ligand_id="ChEBI:CHEBI:16991" FT /ligand_note="DNA primer" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 1082 FT /ligand="RNA" FT /ligand_id="ChEBI:CHEBI:33697" FT /ligand_note="RNA template" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 1113 FT /ligand="DNA" FT /ligand_id="ChEBI:CHEBI:16991" FT /ligand_note="DNA primer" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 1181 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="2" FT /ligand_note="catalytic; for RNase H activity" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00408, FT ECO:0000269|PubMed:22366278" FT BINDING 1181 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="3" FT /ligand_note="catalytic; for RNase H activity" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00408, FT ECO:0000269|PubMed:22366278" FT BINDING 1184 FT /ligand="RNA" FT /ligand_id="ChEBI:CHEBI:33697" FT /ligand_note="RNA template" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 1186 FT /ligand="RNA" FT /ligand_id="ChEBI:CHEBI:33697" FT /ligand_note="RNA template" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 1187 FT /ligand="DNA" FT /ligand_id="ChEBI:CHEBI:16991" FT /ligand_note="DNA primer" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 1214 FT /ligand="DNA" FT /ligand_id="ChEBI:CHEBI:16991" FT /ligand_note="DNA primer" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 1216 FT /ligand="DNA" FT /ligand_id="ChEBI:CHEBI:16991" FT /ligand_note="DNA primer" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 1219 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="3" FT /ligand_note="catalytic; for RNase H activity" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00408, FT ECO:0000269|PubMed:22366278" FT BINDING 1240 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="3" FT /ligand_note="catalytic; for RNase H activity" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00408, FT ECO:0000269|PubMed:22366278" FT BINDING 1242 FT /ligand="RNA" FT /ligand_id="ChEBI:CHEBI:33697" FT /ligand_note="RNA template" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 1266 FT /ligand="RNA" FT /ligand_id="ChEBI:CHEBI:33697" FT /ligand_note="RNA template" FT /evidence="ECO:0000250|UniProtKB:A1Z651" FT BINDING 1310 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="2" FT /ligand_note="catalytic; for RNase H activity" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00408, FT ECO:0000269|PubMed:22366278" FT BINDING 1453 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="4" FT /ligand_note="catalytic; for integrase activity" FT /evidence="ECO:0000250" FT BINDING 1512 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="4" FT /ligand_note="catalytic; for integrase activity" FT /evidence="ECO:0000250" FT SITE 129..130 FT /note="Cleavage; by viral protease p14" FT /evidence="ECO:0000250" FT SITE 213..214 FT /note="Cleavage; by viral protease p14" FT /evidence="ECO:0000250" FT SITE 476..477 FT /note="Cleavage; by viral protease p14" FT /evidence="ECO:0000250" FT SITE 532..533 FT /note="Cleavage; by viral protease p14" FT /evidence="ECO:0000250" FT SITE 657..658 FT /note="Cleavage; by viral protease p14" FT /evidence="ECO:0000250" FT SITE 1328..1329 FT /note="Cleavage; by viral protease p14" FT /evidence="ECO:0000250" FT MOD_RES 190 FT /note="Phosphoserine; by host" FT /evidence="ECO:0000250" FT LIPID 2 FT /note="N-myristoyl glycine; by host" FT /evidence="ECO:0000250" FT STRAND 1167..1169 FT /evidence="ECO:0007829|PDB:3V1O" FT STRAND 1175..1186 FT /evidence="ECO:0007829|PDB:3V1O" FT STRAND 1188..1198 FT /evidence="ECO:0007829|PDB:3V1O" FT STRAND 1200..1209 FT /evidence="ECO:0007829|PDB:3V1O" FT HELIX 1215..1229 FT /evidence="ECO:0007829|PDB:3V1O" FT TURN 1230..1232 FT /evidence="ECO:0007829|PDB:3V1O" FT STRAND 1233..1240 FT /evidence="ECO:0007829|PDB:3V1O" FT HELIX 1242..1249 FT /evidence="ECO:0007829|PDB:3V1O" FT HELIX 1251..1257 FT /evidence="ECO:0007829|PDB:3V1O" FT STRAND 1261..1264 FT /evidence="ECO:0007829|PDB:3V1O" FT STRAND 1268..1270 FT /evidence="ECO:0007829|PDB:3V1Q" FT HELIX 1271..1280 FT /evidence="ECO:0007829|PDB:3V1O" FT STRAND 1283..1291 FT /evidence="ECO:0007829|PDB:3V1O" FT HELIX 1301..1322 FT /evidence="ECO:0007829|PDB:3V1O" SQ SEQUENCE 1733 AA; 193803 MW; 35B226FA584B5122 CRC64; MGQTVTTPLS LTLQHWGDVQ RIASNQSVDV KKRRWVTFCS AEWPTFNVGW PQDGTFNLGV ISQVKSRVFC PGPHGHPDQV PYIVTWEALA YDPPPWVKPF VSPKPPPLPT APVLPPGPSA QPPSRSALYP ALTLSIKSKP PKPQVLPDSG GPLIDLLTED PPPYGVQPSS SARENNEEEA ATTSEVSPPS PMVSRLRGRR DPPAADSTTS QAFPLRMGGD GQLQYWPFSS SDLYNWKNNN PSFSEDPGKL TALIESVLIT HQPTWDDCQQ LLGTLLTGEE KQRVLLEAGK AVRGNDGRPT QLPNEVNAAF PLERPDWDYT TTEGRNHLVL YRQLLLAGLQ NAGRSPTNLA KVKGITQGPN ESPSAFLERL KEAYRRYTPY DPEDPGQETN VSMSFIWQSA PDIGRKLERL EDLKSKTLGD LVREAEKIFN KRETPEEREE RIRREIEEKE ERRRAEDEQR ERERDRRRHR EMSKLLATVV IGQRQDRQGG ERRRPQLDKD QCAYCKEKGH WAKDCPKKPR GPRGPRPQTS LLTLGDXGGQ GQEPPPEPRI TLKVGGQPVT FLVDTGAQHS VLTQNPGPLS DKSAWVQGAT GGKRYRWTTD RKVHLATGKV THSFLHVPDC PYPLLGRDLL TKLKAQIHFE GSGAQVVGPM GQPLQVLTLN IENKYRLHET SKEPDVPLGS TWLSDFPQAW AETGGMGLAV RQAPLIIPLK ATSTPVSIKQ YPMSQEARLG IKPHIQRLLD QGILVPCQSP WNTPLLPVKK PGTNDYRPVQ DLREVNKRVE DIHPTVPNPY NLLSGLPPSH QWYTVLDLKD AFFCLRLHPT SQPLFAFEWR DPEMGISGQL TWTRLPQGFK NSPTLFDEAL HRDLADFRIQ HPDLILLQYV DDLLLAATSE QDCQRGTRAL LQTLGNLGYR ASAKKAQICQ KQVKYLGYLL KEGQRWLTEA RKETVMGQPT PKTPRQLREF LGTAGFCRLW IPGFAEMAAP LYPLTKTGTL FNWGPDQQKA YQEIKQALLT APALGLPDLT KPFELFVDEK QGYAKGVLTQ KLGPWRRPVA YLSKKLDPVA AGWPPCLRMV AAIAVLTKDA GKLTMGQPLV ILAPHAVEAL VKQPPDRWLS NARMTHYQAM LLDTDRVQFG PVVALNPATL LPLPEKEAPH DCLEILAETH GTRPDLTDQP IPDADYTWYT DGSSFLQEGQ RRAGAAVTTE TEVIWARALP AGTSAQRAEL IALTQALKMA EGKKLNVYTD SRYAFATAHV HGEIYRRRGL LTSEGREIKN KNEILALLKA LFLPKRLSII HCPGHQKGNS AEARGNRMAD QAAREAAMKA VLETSTLLIE DSTPYTPPHF HYTETDLKRL RELGATYNQT KGYWVLQGKP VMPDQSVFEL LDSLHRLTHP SPQKMKALLD REESPYYMLN RDRTIQYVTE TCTACAQVNA SKAKIGAGVR VRGHRPGTHW EVDFTEVKPG LYGYKYLLVF VDTFSGWVEA FPTKRETAKV VTKKLLEDIF PRFGMPQVLG SDNGPAFASQ VSQSVADLLG IDWKLHCAYR PQSSGQVERM NRTIKETLTK LTLASGTRDW VLLLPLALYR ARNTPGPHGL TPYEILYGAP PPLVNFHDPE MSKLTNSPSL QAHLQALQAV QQEVWKPLAA AYQDQLDQPV IPHPFRVGDA VWVRRHQTKN LEPRWKGPYT VLLTTPTALK VDGISAWIHA AHVKAATTPP AGTAWKVQRS QNPLKIRLTR GAP //